These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35340932)

  • 41. Visible-Light-Mediated Click Chemistry for Highly Regioselective Azide-Alkyne Cycloaddition by a Photoredox Electron-Transfer Strategy.
    Wu ZG; Liao XJ; Yuan L; Wang Y; Zheng YX; Zuo JL; Pan Y
    Chemistry; 2020 May; 26(25):5694-5700. PubMed ID: 31953964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bioorthogonal activation of prodrugs, for the potential treatment of breast cancer, using the Staudinger reaction.
    Mitry MMA; Boateng SY; Greco F; Osborn HMI
    RSC Med Chem; 2023 Aug; 14(8):1537-1548. PubMed ID: 37593579
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acrolein preferentially damages nucleolus eliciting ribosomal stress and apoptosis in human cancer cells.
    Wang HT; Chen TY; Weng CW; Yang CH; Tang MS
    Oncotarget; 2016 Dec; 7(49):80450-80464. PubMed ID: 27741518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intracellular fluorogenic supramolecular assemblies for self-reporting bioorthogonal prodrug activation.
    Zhao Y; Yao Q; Chen J; Zhang R; Song J; Gao Y
    Biomater Sci; 2022 Sep; 10(19):5662-5668. PubMed ID: 35996984
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fabrication of redox-responsive doxorubicin and paclitaxel prodrug nanoparticles with microfluidics for selective cancer therapy.
    Ma X; Özliseli E; Zhang Y; Pan G; Wang D; Zhang H
    Biomater Sci; 2019 Jan; 7(2):634-644. PubMed ID: 30534690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cigarette Smoke Containing Acrolein Contributes to Cisplatin Resistance in Human Bladder Cancers through the Regulation of HER2 Pathway or FGFR3 Pathway.
    Hong JH; Tong ZJ; Wei TE; Lu YC; Huang CY; Huang CY; Chiang CH; Jaw FS; Cheng HW; Wang HT
    Mol Cancer Ther; 2022 Jun; 21(6):1010-1019. PubMed ID: 35312783
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design, Synthesis, and Biological Evaluation of a Conjugate of 5-Fluorouracil and an LSD1 Inhibitor.
    Ota Y; Nakamura A; Elboray EE; Itoh Y; Suzuki T
    Chem Pharm Bull (Tokyo); 2019 Mar; 67(3):192-195. PubMed ID: 30369513
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
    Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
    Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dipeptidyl peptidase IV as a potential target for selective prodrug activation and chemotherapeutic action in cancers.
    Dahan A; Wolk O; Yang P; Mittal S; Wu Z; Landowski CP; Amidon GL
    Mol Pharm; 2014 Dec; 11(12):4385-94. PubMed ID: 25365774
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and biological evaluation of an albumin-binding prodrug of doxorubicin that is cleaved by prostate-specific antigen (PSA) in a PSA-positive orthotopic prostate carcinoma model (LNCaP).
    Graeser R; Chung DE; Esser N; Moor S; Schächtele C; Unger C; Kratz F
    Int J Cancer; 2008 Mar; 122(5):1145-54. PubMed ID: 17973264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxaliplatin-Based Platinum(IV) Prodrug Bearing Toll-like Receptor 7 Agonist for Enhanced Immunochemotherapy.
    Tang L; Cai D; Qin M; Lu S; Hu MH; Ruan S; Jin G; Wang Z
    ACS Omega; 2020 Jan; 5(1):726-734. PubMed ID: 31956823
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An improved synthesis of lysosomal activated mustard prodrug for tumor-specific activation and its cytotoxic evaluation.
    Adidala R; Devalapally H; Srivari C; Devarakonda R K; Akkinepally RR
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1047-53. PubMed ID: 22185667
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Electrophilic Azides for Materials Synthesis and Chemical Biology.
    Xie S; Sundhoro M; Houk KN; Yan M
    Acc Chem Res; 2020 Apr; 53(4):937-948. PubMed ID: 32207916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.
    Platt VM; Szoka FC
    Mol Pharm; 2008; 5(4):474-86. PubMed ID: 18547053
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prodrug strategy for cancer cell-specific targeting: A recent overview.
    Zhang X; Li X; You Q; Zhang X
    Eur J Med Chem; 2017 Oct; 139():542-563. PubMed ID: 28837920
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two birds with one stone: Copper metal-organic framework as a carrier of disulfiram prodrug for cancer therapy.
    Pan Q; Xie L; Liu R; Pu Y; Wu D; Gao W; Luo K; He B
    Int J Pharm; 2022 Jan; 612():121351. PubMed ID: 34883206
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Zosuquidar and an albumin-binding prodrug of zosuquidar reverse multidrug resistance in breast cancer cells of doxorubicin and an albumin-binding prodrug of doxorubicin.
    Abu Ajaj K; Graeser R; Kratz F
    Breast Cancer Res Treat; 2012 Jul; 134(1):117-29. PubMed ID: 22228402
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anticancer activities of emetine prodrugs that are proteolytically activated by the prostate specific antigen (PSA) and evaluation of in vivo toxicity of emetine derivatives.
    Akinboye ES; Rosen MD; Bakare O; Denmeade SR
    Bioorg Med Chem; 2017 Dec; 25(24):6707-6717. PubMed ID: 29153549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.
    Gupta D; Varghese Gupta S; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
    Mol Pharm; 2013 Feb; 10(2):512-22. PubMed ID: 23244438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.